Can Digitally Delivered First-line Osteoarthritis Treatment Improve Equal Access to Care
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJoint Academy
About this trial
To improve chronically ill patients' health and quality of life, long-standing and continuous treatment is needed at an acceptable cost. The purpose of this study was to compare utilization of digital versus face-to-face delivered osteoarthritis (OA) treatment in the 21 different county councils of Sweden that are responsible for providing healthcare to the residents.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Radiographic and or clinical diagnosis of hip or knee OA from a physical therapist or physician (95% of all patients in previously published studies). Individuals without a prior diagnosis had clinical OA confirmed by an orthopaedic surgeon or physiotherapist via telephone (diagnosis according to National Institute for Health and Care Excellence (NICE) criteria and Swedish National Guidelines, and confirming the absence of any red flag symptoms), or if deemed necessary were recommended to seek face-to-face care before inclusion in the programme.
From October 1st 2021, all patients should have undergone a physical examination by doctor or physiotherapists before being able to enter the treatment.
Disqualifiers
None
Trial population
Participants with knee or hip OA that have joined the digital OA treatment program via online advertisements and campaigns placed on search engines and social networks, or by recommendations by their local physiotherapist or orthopaedic surgeon. Procedure for inclusion and exclusion has been described above. Data will be extracted from the Joint Academy (JA) database and the Better management of patients with OsteoArthritis (BOA) registry.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Digitally delivered first-line treatment for osteoarthritis
BehavioralDigitally delivered first-line for osteoarthritis through the caregiver Joint Academy.
Face-to-face first-line treatment for osteoarthritis
BehavioralFirst-line for osteoarthritis delivered at a primary care clinic face-to-face with reported data to the BOA registry.
Treatment groups
50,000 Participants
are divided into 2 treatment groupsGroup A: Joint Academy1 intervention
Group B: BOA1 intervention
Trial outcomes
Primary outcomes
1
Postal code/Official Municipality Key
Postal code/Official Municipality Key of participants
Time frame
Baseline2
Postal code/Official Municipality Key for primary care center
For the BOA group only
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov